Loading...
Market
Total number of countries approving MVA-BN vaccine by end of 2024?
2
Resolution / Starting Odds
1-5 • 25%
6-10 • 25%
11-15 • 25%
More than 15 • 25%
Official announcements from relevant national health authorities
Story
WHO Prequalifies Bavarian Nordic's MVA-BN Vaccine as First Mpox Shot on Friday, Approved in Mexico
Sep 13, 2024, 09:45 AM
The World Health Organization (WHO) has prequalified the MVA-BN vaccine, developed by Bavarian Nordic, as the first vaccine against mpox. This approval, announced on Friday, marks a significant step towards expanding access and reducing transmission in high-risk communities. Additionally, the vaccine has been approved for emergency use in Mexico by Cofepris.
View original story
Similar markets
Nigeria • 25%
Democratic Republic of Congo • 25%
Kenya • 25%
Other • 25%
Less than 10 • 25%
10 to 20 • 25%
20 to 30 • 25%
More than 30 • 25%
0-10 countries • 25%
11-20 countries • 25%
21-30 countries • 25%
31+ countries • 25%
1-5 countries • 25%
6-10 countries • 25%
11-15 countries • 25%
More than 15 countries • 25%
0-10 countries • 25%
11-20 countries • 25%
21-30 countries • 25%
31+ countries • 25%
Yes • 50%
No • 50%
Less than 10 countries • 25%
10 to 20 countries • 25%
21 to 30 countries • 25%
More than 30 countries • 25%
No countries • 25%
1 to 5 countries • 25%
6 to 10 countries • 25%
More than 10 countries • 25%
0-2 countries • 25%
3-5 countries • 25%
6-8 countries • 25%
9 or more countries • 25%
1-5 • 25%
6-10 • 25%
11-15 • 25%
16 or more • 25%
More than 20 countries • 33%
10 to 20 countries • 34%
Less than 10 countries • 33%